Nanotechnology translation in vascular diseases: From design to the bench
WIREs Nanomedicine and Nanobiotechnology · 2024
DOI: 10.1002/wnan.1919 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2024. Verfasst von Yongwen Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of C…. Hauptthemen laut MEDLINE: Nanostructures, Nanoparticles, Vascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 127 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Atherosclerosis is a systemic pathophysiological condition contributing to the development of majority of polyvascular diseases. Nanomedicine is a novel and rapidly developing science. Due to their small size, nanoparticles are freely transported in vasculature, and have been widely employed as tools in analytical imaging techniques. Furthermore, the application of nanoparticles also allows target intervention, such as drug delivery and tissue engineering regenerative methods, in the management of major vascular diseases. Therefore, by summarizing the physical and chemical characteristics of common nanoparticles used in diagnosis and treatment of vascular diseases, we discuss the details of these applications from cellular, molecular, and in vivo perspectives in this review. Furthermore, we also summarize the status and challenges of the application of nanoparticles in clinical translation. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Cardiovascular Disease Implantable Materials and Surgical Technologies > Nanomaterials and Implants Therapeutic Approaches and Drug Discovery > Emerging Technologies
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
ORCID-Profile: Sihui Luo, Xueying Zheng
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Zhou, Y., Yue, T., Ding, Y., Tan, H., Weng, J., Luo, S., & Zheng, X. (2024). Nanotechnology translation in vascular diseases: From design to the bench. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1919
Vancouver
Zhou Y, Yue T, Ding Y, Tan H, Weng J, Luo S, et al. Nanotechnology translation in vascular diseases: From design to the bench. WIREs Nanomedicine and Nanobiotechnology. 2024. doi:10.1002/wnan.1919
BibTeX
@article{Zhou2024,
author = {Zhou, Yongwen and Yue, Tong and Ding, Yu and Tan, Huiling and Weng, Jianping and Luo, Sihui and Zheng, Xueying},
title = {Nanotechnology translation in vascular diseases: From design to the bench},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2024},
doi = {10.1002/wnan.1919}
}
EUVIMED